Tamsulosin and Dermatitis atopic aggravated - a phase IV clinical study of FDA data

Summary:

Dermatitis atopic aggravated is reported as a side effect among people who take Tamsulosin (tamsulosin), especially for people who are male, 60+ old, also take Dupixent, and have Neurodermatitis.

The phase IV clinical study analyzes which people have Dermatitis atopic aggravated when taking Tamsulosin. It is created by eHealthMe based on reports of 70,950 people who have side effects when taking Tamsulosin from the FDA, and is updated regularly.

What is Tamsulosin?

Tamsulosin has active ingredients of tamsulosin. It is often used in prostate examination abnormal. eHealthMe is studying from 72,635 Tamsulosin users. Check the latest studies of Tamsulosin.

What is Dermatitis atopic aggravated?

Dermatitis atopic aggravated (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 610 drugs and 179 conditions by eHealthMe. Check the latest studies of Dermatitis atopic aggravated.

On Jul, 17, 2026

70,950 people reported to have side effects when taking Tamsulosin.
Among them, 71 people (0.1%) have Dermatitis atopic aggravated.

Could Tamsulosin cause Dermatitis atopic aggravated?

Among these 71 people:

What is the gender of people who have Dermatitis atopic aggravated when taking Tamsulosin? *

female: 0.0 %
male: 100 %

What is the age of people who have Dermatitis atopic aggravated when taking Tamsulosin? *

What are other drugs people take besides Tamsulosin? *

What are other side effects people have besides Dermatitis atopic aggravated? *

Rashes (redness): 27 people, 38.03%
Itching: 15 people, 21.13%
Drug Ineffective: 11 people, 15.49%
Discomfort: 11 people, 15.49%
Fever: 10 people, 14.08%
Pain: 10 people, 14.08%
Sleep Disorder: 10 people, 14.08%
Nausea And Vomiting: 7 people, 9.86%
Skin Atrophy (wasting of skin): 7 people, 9.86%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 7 people, 9.86%

What are the existing conditions these people have? *

Pain: 7 people, 9.86%
Neurodermatitis (a skin disorder characterized by long lasting itching and scratching): 7 people, 9.86%
Neuralgia (pain in one or more nerves): 6 people, 8.45%
Hypolipidaemia (an abnormally high concentration of fats or lipids in the blood): 6 people, 8.45%
Neurological Symptom (symptoms of nervous system disease): 6 people, 8.45%
Joint Pain: 5 people, 7.04%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 5 people, 7.04%
Type 2 Diabetes: 5 people, 7.04%
High Blood Pressure: 4 people, 5.63%
Asthma: 4 people, 5.63%

* Approximation only. Some reports may have incomplete information.

Do you take Tamsulosin and have Dermatitis atopic aggravated?

- Check whether Dermatitis atopic aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tamsulosin:

Tamsulosin (72,635 reports)

Browse all side effects of Tamsulosin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis atopic aggravated:

Dermatitis atopic aggravated (610 drugs)

Browse all the conditions that are associated with Dermatitis atopic aggravated:

Dermatitis atopic aggravated (179 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tamsulosin (the active ingredients of Tamsulosin) and Tamsulosin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.